Epione Pharmaceuticals Private Limited, a active private limited company, was established on 21 June 2012 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233PN2012PTC143777. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 124 professional, Its leadership includes Pankaj Shah Sumatilal (Director), Vipul Shah Pankaj (Director), Rekha Shah Pankaj (Director). Past directors included Pankaj Shah Sumatilal, Vipul Shah Pankaj, Rekha Shah Pankaj. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No.804, 8Th Floor,Suyog Center, Jawaharlal Nehru Road, Market Yard-Gulte, Kdi, Pune, Maharashtra, 411037.
U24233PN2012PTC143777
143777
21 June 2012
₹1.00 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Epione Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Shah Sumatilal | Director | 29 Nov 2021 | Current |
| Vipul Shah Pankaj | Director | 29 Nov 2021 | Current |
| Rekha Shah Pankaj | Director | 10 Apr 2018 | Current |
| Rushika Shah Vipul | Director | 16 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 18 May 2018 | Past |
| Pramod Abcsdd | Managing Director | 18 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epione Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 11.09% increase. The company also saw a substantial fall in profitability, with a 34.56% decrease in profit. The company's net worth Soared by an impressive increase of 21.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Epione Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Epione Pharmaceuticals has a workforce of 124 employees as of Mar 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Epione Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epione Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Epione Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Epione Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Pankaj Shah Sumatilal was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 4 years 27 days . was documented.
The activity Vipul Shah Pankaj was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 4 years 27 days . was completed.
Rekha Shah Pankaj was appointed as a Director was appointed as a Director on 10 Apr 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Rushika Shah Vipul was appointed as a Director was appointed as a Director on 16 Jan 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
The CIN of Epione Pharmaceuticals Private Limited is U24233PN2012PTC143777.
Epione Pharmaceuticals Private Limited is headquartered at Office No.804, 8Th Floor,Suyog Center, Jawaharlal Nehru Road, Market Yard-Gulte, Kdi, Pune, Maharashtra, 411037.
Epione Pharmaceuticals Private Limited was incorporated on 21 June 2012.
The current directors of Epione Pharmaceuticals Private Limited are
The primary industry of Epione Pharmaceuticals Private Limited is Trade.
Epione Pharmaceuticals Private Limited is unlisted.
The authorized capital of Epione Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Epione Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX